News

PHILADELPHIA.Today on MSN2mon
Iovance Biotherapeutics Likely to Add Hundreds of New Jobs At Philadelphia Navy Yard
As part of an effort to increase its cell therapy manufacturing, Iovance Biotherapeutics is planning to add hundreds of new ...
The Business Journals1y
Iovance stock soars on FDA approval of its melanoma gene therapy
Iovance has its gene therapy manufacturing plant at the Philadelphia Navy Yard. Iovance officially opens $125M cell therapy center at the Navy Yard © 2025 American ...
The New York Times1mon
In Philadelphia, a Former Navy Yard Wins on Sustainability
The Navy Yard developers have plans for 38 more buildings ... Image The development is currently home to commercial tenants, including Iovance Biotherapeutics, but residents will arrive this ...
Seeking Alpha1y
Iovance: Approval For Historic Solid Tumor Targeting TIL Therapy Likely, Outlook Promising
Iovance's tumor infiltrating lymphocyte cell ... and has its own "built-to-suit", 136k square foot facility in Navy Yard, Philadelphia, which can presently treat hundreds of patients each year ...
Seeking Alpha1y
Iovance Biotherapeutics: Why The Stock Is Tanking Ahead Of A Major Approval Catalyst
Iovance also has developed an efficient 22-day GMP manufacturing process at its 136,00-square-foot cell therapy centre in Navy Yard, Philadelphia. Although the center is only capable of treating ...
AOL1mon
Iovance Biotherapeutics Stock Is Crashing. And Here's Why Things Could Get Even Worse This Year.
Iovance Biotherapeutics (NASDAQ: IOVA) is a stock that many investors think has a lot of upside. A year ago, regulators approved its cellular therapy, Amtagvi, to treat unresectable (inoperable ...